Literature DB >> 7525024

Autonomic and sensory cardiovascular activities of nonivamide: intrathecal administration of clonidine.

Y C Lo1, J L Yeh, J R Wu, J M Yang, S J Chen, I J Chen.   

Abstract

The effects of nonivamide on the cardiovascular system were examined and compared with the effects of substance P (SP) in rats. Intravenous (i.v.) injection (10 micrograms/kg) of nonivamide produced triphasic pressure responses (A; depressor, B; pressor, and C; depressor) and biphasic bradycardia responses (f; fast bradycardia and s; slow bradycardia). IA injection (10 micrograms/kg) into the epigastric artery caused hypotension and mild tachycardia. The effects of atropine, vagotomy, SP antagonist, propranolol, and clonidine on these responses were examined and mechanisms responsible for the nonivamide-induced responses are postulated as follows. A and f are due to vagal reflex resulting from the excitation of afferent sensory neurons in the heart and are parasympathetic efferent effects from the nucleus solitarius. B is involved in sympathetic activation, partly caused by the release of SP in the spinal cord. C is due to the vasodilatory effect of SP released from perivascular stores. s was diminished by vagotomy and is due to the bradycardiac effect of acetylcholine, released by SP, from cardiac stores. The activation of the autonomic system is inhibited by clonidine and involved in the wide spectrum of nonivamide-induced cardiovascular effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525024     DOI: 10.1016/0361-9230(94)90210-0

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  2 in total

1.  Transient receptor potential vanilloid subtype 1 channel mediated neuropeptide secretion and depressor effects: role of endoplasmic reticulum associated Ca2+ release receptors in rat dorsal root ganglion neurons.

Authors:  Wei Huang; Hui Wang; James J Galligan; Donna H Wang
Journal:  J Hypertens       Date:  2008-10       Impact factor: 4.844

2.  Capsinolol: the first beta-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart.

Authors:  I J Chen; J L Yeh; Y C Lo; S H Sheu; Y T Lin
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.